Evidence map›Paper›PMID 38310902›Full record

Trial reportThe lancet. Healthy longevity2024

Behavioural activation to mitigate the psychological impacts of COVID-19 restrictions on older people in England and Wales (BASIL+): a pragmatic randomised controlled trial.

Simon Gilbody, Elizabeth Littlewood, Dean McMillan, Lucy Atha, Della Bailey, Kalpita Baird, Samantha Brady, Lauren Burke, Carolyn A Chew-Graham, Peter Coventry and 21 more

Open access · goldAbstract readRandomized Controlled TrialPragmatic Clinical Trial
In one paragraph

Trial report in The lancet. Healthy longevity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
22.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. [Interpretation and Examples: Key Updates in CONSORT 2025].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors at 8 institutions in 1 country.

Simon GilbodyDepartment of Health Sciences, University of York, York, UK; Hull York Medical School, University of York, York, UK. Electronic address: simon.gilbody@york.ac.uk.
Elizabeth LittlewoodDepartment of Health Sciences, University of York, York, UK; Tees, Esk and Wear Valleys NHS Foundation Trust, Research & Development, Flatts Lane Centre, Middlesbrough, UK.
Dean McMillanDepartment of Health Sciences, University of York, York, UK; Hull York Medical School, University of York, York, UK; Tees, Esk and Wear Valleys NHS Foundation Trust, Research & Development, Flatts Lane Centre, Middlesbrough, UK.
Lucy AthaDepartment of Health Sciences, University of York, York, UK.
Della BaileyDepartment of Health Sciences, University of York, York, UK.
Kalpita BairdDepartment of Health Sciences, University of York, York, UK.
Samantha BradyDepartment of Health Sciences, University of York, York, UK.
Lauren BurkeDepartment of Health Sciences, University of York, York, UK.
Carolyn A Chew-GrahamSchool of Medicine, Keele University, Staffordshire, UK.
Peter CoventryDepartment of Health Sciences, University of York, York, UK; York Environmental Sustainability Institute, University of York, York, UK.
Suzanne CroslandDepartment of Health Sciences, University of York, York, UK.
Caroline FairhurstDepartment of Health Sciences, University of York, York, UK.
Andrew HenryDepartment of Health Sciences, University of York, York, UK; Tees, Esk and Wear Valleys NHS Foundation Trust, Research & Development, Flatts Lane Centre, Middlesbrough, UK.
Kelly HollingsworthDepartment of Health Sciences, University of York, York, UK; Tees, Esk and Wear Valleys NHS Foundation Trust, Research & Development, Flatts Lane Centre, Middlesbrough, UK.
Elizabeth NewbronnerDepartment of Health Sciences, University of York, York, UK.
Eloise RydeDepartment of Health Sciences, University of York, York, UK; Tees, Esk and Wear Valleys NHS Foundation Trust, Research & Development, Flatts Lane Centre, Middlesbrough, UK.
Leanne ShearsmithSchool of Medicine, University of Leeds, Leeds, UK.
Han-I WangDepartment of Health Sciences, University of York, York, UK.
Judith WebsterPatient and Public Representative, Thornton-le-Dale, UK.
Rebecca WoodhouseDepartment of Health Sciences, University of York, York, UK.
Andrew CleggSchool of Medicine, University of Leeds, Leeds, UK.
Sarah Dexter-SmithTees, Esk and Wear Valleys NHS Foundation Trust, Research & Development, Flatts Lane Centre, Middlesbrough, UK.
Tom GentryAge UK, London, UK.
Catherine HewittDepartment of Health Sciences, University of York, York, UK.
Andrew HillSchool of Medicine, University of Leeds, Leeds, UK.
Karina LovellDivision of Nursing, Midwifery & Social Work, University of Manchester, Manchester, UK.
Claire SloanDepartment of Health Sciences, University of York, York, UK.
Gemma Traviss-TurnerSchool of Medicine, University of Leeds, Leeds, UK.
Steven PrattNIHR Clinical Research Network, Newcastle, UK.
David EkersDepartment of Health Sciences, University of York, York, UK; Tees, Esk and Wear Valleys NHS Foundation Trust, Research & Development, Flatts Lane Centre, Middlesbrough, UK.
BASIL trials collective
University of York · GBUniversity of Leeds · GBTees, Esk and Wear Valleys NHS Foundation Trust · GBAge UK · GBKeele University · GBNIHR Clinical Research Network · GBThornton and Ross (United Kingdom) · GBUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOlder adults were more likely to be socially isolated during the COVID-19 pandemic, with increased risk of depression and loneliness. We aimed to investigate whether a behavioural activation intervention delivered via telephone could mitigate depression and loneliness in at-risk older people during the COVID-19 pandemic.

methodsBASIL+ (Behavioural Activation in Social Isolation) was a pragmatic randomised controlled trial conducted among patients recruited from general practices in England and Wales, and was designed to assess the effectiveness of behavioural activation in mitigating depression and loneliness among older people during the COVID-19 pandemic. Eligible participants were aged 65 years and older, socially isolated, with a score of 5 or higher on the Patient Health Questionnaire-9 (PHQ-9), and had multiple long-term conditions. Participants were allocated in a 1:1 ratio to the intervention (behavioural activation) or control groups by use of simple randomisation without stratification. Behavioural activation was delivered by telephone; participants were offered up to eight weekly sessions with trained BASIL+ Support Workers. Behavioural activation was adapted to maintain social connections and encourage socially reinforcing activities. Participants in the control group received usual care with existing COVID-19 wellbeing resources. The primary clinical outcome was self-reported depression severity, assessed by the PHQ-9, at 3 months. Outcomes were assessed masked to allocation and analysis was by treatment allocation. This trial is registered with the ISRCTN registry (ISRCTN63034289).

findingsBetween Feb 8, 2021, and Feb 28, 2022, 449 eligible participants were identified and 435 from 26 general practices were recruited and randomly assigned (1:1) to the behavioural activation intervention (n=218) or to the control group (usual care with signposting; n=217). The mean age of participants was 75·7 years (SD 6·7); 270 (62·1%) of 435 participants were female, and 418 (96·1%) were White. Participants in the intervention group attended an average of 5·2 (SD 2·9) of eight remote behavioural activation sessions. The adjusted mean difference in PHQ-9 scores between the control and intervention groups at 3 months was -1·65 (95% CI -2·54 to -0·75, p=0·0003). No adverse events were reported that were attributable to the behavioural activation intervention.

interpretationBehavioural activation is an effective and potentially scalable intervention that can reduce symptoms of depression and emotional loneliness in at-risk groups in the short term. The findings of this trial add to the range of strategies to improve the mental health of older adults with multiple long-term conditions. These results can be helpful to policy makers beyond the pandemic in reducing the global burden of depression and addressing the health impacts of loneliness, particularly in at-risk groups.

fundingUK National Institute for Health and Care Research.

Indexed as

COVID-19Ocimum basilicumAgedEnglandFemaleHumansMalePandemicsWales

Identifiers

PMID38310902
PMCPMC10834375
OpenAlexW4391544957

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.